What's New in the Management of Insomnia:
Managed Care Considerations in an
Evolving Treatment Landscape

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the webinars held on March 14 and March 28, 2018

This activity is valid from April 10, 2018 to April 30, 2019

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Merck and Co.

Description:
The program will be on newer therapies in insomnia management, with a close look at the role of orexin receptor antagonists. The program will focus on elderly insomnia patients, which is a particular need among our membership. The activity will also touch on the management of middle aged women who suffer from insomnia. The program will discuss the importance of provider/patient communication, and how communication can be improved among all parties, including payers, to improve patient adherence & outcomes.

Upon Completion of this activity, participants will be able to:

  • Describe the role of orexin receptor antagonists in the management of insomnia

  • Apply recently developed diagnostic criteria for insomnia disorder to evaluations of older patients

  • Analyze the various recommended treatments for insomnia including pharmacologic and nonpharmacologic measures for specific patient populations

  • Discuss the management of middle aged women who suffer from insomnia and how they may differ from other populations

  • Examine strategies to improve communication between providers and patients to improve adherence and outcomes in insomnia
     

Faculty: Larry Culpepper, MD, MPH
Professor of Family Medicine
Department of Family Medicine
Boston University School of Medicine
Vanderbilt-Ingram Cancer Center

Disclosure:

Dr. Culpepper serves on an advisory board or panel for Alkermes, Jazz Pharmaceuticals, Merck, Sunovion Pharmaceuticals, Inc. He serves as a consultant for Lundbeck A/S Foundation, receives royalties from UpToDate, is Editor-in-Chief of the Physicians Postgraduate Press, and self-manages stock in M-3 Information, LLC. His Presentation has been reviewed for any bias.
 
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Merck and Co.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue